Cargando…
COVID-19 in 7 multiple sclerosis patients in treatment with ANTI-CD20 therapies
BACKGROUND AND AIM: In December 2019, the first cases of SARS-CoV-2 infection were detected in Wuhan. Within two months, it had begun to spread around the world in what became an unprecedented pandemic. Patients with Multiple Sclerosis (MS) in a state of immunosuppression may be considered at risk f...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295509/ https://www.ncbi.nlm.nih.gov/pubmed/32585617 http://dx.doi.org/10.1016/j.msard.2020.102306 |